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With great interest we read the recent article in this journal by
Tornero et al. [1], who reported their experience with the
treatment of periprosthetic joint infections (PJI) due to
Enterococcus sp. Overall, of the 178 cases they report a success
rate of 48% after open debridement, 19% after one-stage ex-
change, and 34% after two-stage exchange. Outcome was based
on the absence of inﬂammatory signs that remained or reap-
peared during or after completing antibiotic treatment or the
need for unplanned surgery. In addition, they observed a pol-
ymicrobial infection in 54% of cases, which was correlated with
a higher failure rate (52% vs. 36%, p 0.042), compared with
monomicrobial infections. In this multicentre retrospective
study, information was obtained from different centres where
the decision for surgical approach (timing, procedure) or anti-
biotic treatment relied on many different physicians and local
protocols.
In our institution, the treatment of choice in early PJI is open
debridement and retention of the implant, followed by a strict
antibiotic regimen. Therefore, we would like to present treat-
ment results of a consecutive group of 44 patients with an early
PJI (< 3 months after the implantation) with Enterococcus sp. as
an addition to the aforementioned study.
Enterococci are known as antibiotic-resistant opportunistic
pathogens. In cases of PJI, they are often seen as part of poly-
microbial ﬂora and are classiﬁed as difﬁcult to treat, andClinical Microbiology and Infection © 2015 European Society of Ctherefore two-stage exchange is recommended [2]. Debride-
ment, antibiotics and implant retention is the treatment of
choice in early PJI [2,3].
The institutional review board of the St. Maartenskliniek
Nijmegen approved the study protocol. Medical records of all
patients who underwent primary or revision joint replacement
arthroplasty at our institution between 2009 and 2013 were
retrospectively reviewed for early PJI with Enterococcus sp. with
a mean follow-up 678 days (140 to 1642).
During the index operations, all patients received a pro-
phylactic dose of 2 g of cefazolin in case of primary arthroplasty
and empirically after tissue biopsies were collected for culture
in case of revision arthroplasty. During the surgical debride-
ment, six biopsies were obtained for microbiological analysis.
Meticulous debridement of all synovial tissue was performed to
enable posterior access and debridement. A targeted antibiotic
regimen was started for 3 months in every case as soon as
culture results provided the causative microorganism.
Patients’ records were evaluated for adverse events until
follow-up. Failure was concluded in case of an unplanned sur-
gery or the presence of persistent infectious symptoms ac-
cording to the Musculoskeletal Infection Society (MSIS) criteria
[4]. We identiﬁed 44 patients with a mean age of 71 years
(range 52 to 87) diagnosed with early Enterococcus sp. peri-
prosthetic joint infection with a mean follow-up period of 678
days (Table 1). Debridement was performed at an average of 15
days after the index implantation. In 35 patients (80%), the
infection was polymicrobial.
Patients were either treated with teicoplanin 400 mg,
rifampicin 450 mg, vancomycin or amoxicillin 500 mg or a
combination of these antibiotics for 3 months postoperatively.
At the latest follow-up, radiographic analysis showed no loos-
ening of the prostheses nor osteolytic bone loss. The prosthesis
could be retained in 29 patients (66%), and 15 cases were
considered a failure, based on the presence or absence of in-
ﬂammatory symptoms according to the Musculoskeletal Infec-
tion Society (MSIS) criteria [4]. Four total hip replacement
patients were successfully treated with a two-stage revision.
Comparing our success rate after debridement and retention
of the implant with the results of Tornero et al. (66% vs. 48%),
we suggest that a standardized protocol for treatment of early
PJI as described earlier is fundamental for achieving good results
after debridement, antibiotics, irrigation, and retention pro-
cedures in the approach to early Enterococcus sp.–associated
PJI. Furthermore, despite the fact that our study population had
a high a polymicrobial infection rate, implying a high chance of
failure, we obtained a reasonable outcome. In addition, because
implant related infections are complex problems, weekly
scheduled multidisciplinary consultation (orthopaedic surgeon,Clin Microbiol Infect 2015; 21: e41–e42
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TABLE 1. Study ﬁndings
Findings n
Male 16
Location of periprosthetic joint infections
Hip 28
Knee 16
Primary prostheses
Hip 16
Knee 12
Revision prostheses
Hip 4
Knee 12
Risk factors
Diabetes mellitus 8
Rheumatoid arthritis 3
Retention after debridement, antibiotics, irrigation, and retention
Hip 20
Knee 9
Failure
Hip 8
Knee 7
e42 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIinfectious disease specialist, clinical microbiologist, infection
control nurse, and pharmacist) might beneﬁt the outcome of
PJI.
Considering the expected increase of both total hip and knee
arthroplasty and prosthetic joint revision surgery, it isClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectimportant to deﬁne treatment strategies for the accompanying
increase in the number of infectious complications of these
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